Medication adherence issues in patients treated for COPD

Although medical treatment of COPD has advanced, nonadherence to medication regimens poses a significant barrier to optimal management. Underuse, overuse, and improper use continue to be the most common causes of poor adherence to therapy. An average of 40%–60% of patients with COPD adheres to the prescribed regimen and only 1 out of 10 patients with a metered dose inhaler performs all essential steps correctly. Adherence to therapy is multifactorial and involves both the patient and the primary care provider. The effect of patient instruction on inhaler adherence and rescue medication utilization in patients with COPD does not seem to parallel the good results reported in patients with asthma. While use of a combined inhaler may facilitate adherence to medications and improve efficacy, pharmacoeconomic factors may influence patient’s selection of both the device and the regimen. Patient’s health beliefs, experiences, and behaviors play a significant role in adherence to pharmacological therapy. This manuscript reviews important aspects associated with medication adherence in patients with COPD and identifies some predictors of poor adherence.

[1]  S. Bannister,et al.  A Qualitative Study , 2009 .

[2]  A. Park,et al.  CENTER FOR DRUG EVALUATION AND RESEARCH , 2009 .

[3]  B. Riley,et al.  CENTER FOR DRUG EVALUATION AND RESEARCH , 2009 .

[4]  C. Mullins,et al.  Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care system. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  C. P. Schayck,et al.  Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. , 2008, Family practice.

[6]  R. Dhand,et al.  Aerosol delivery during mechanical ventilation: from basic techniques to new devices. , 2008, Journal of aerosol medicine and pulmonary drug delivery.

[7]  D. Haupt,et al.  Medication persistence among patients with asthma/COPD drugs , 2008, Pharmacy World & Science.

[8]  L. Ring,et al.  Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10‐year period , 2007, Journal of clinical pharmacy and therapeutics.

[9]  T. Lasserson,et al.  Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[10]  L. Ring,et al.  Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication , 2007, Pharmacoepidemiology and drug safety.

[11]  Bernhard Gleich,et al.  Targeted delivery of magnetic aerosol droplets to the lung , 2007, Nature Nanotechnology.

[12]  R. Negro,et al.  Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients , 2007, International journal of chronic obstructive pulmonary disease.

[13]  M. Dimatteo,et al.  Health Beliefs, Disease Severity, and Patient Adherence: A Meta-Analysis , 2007, Medical care.

[14]  S. Colman,et al.  Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy. , 2007, The American journal of medicine.

[15]  Yugi Oba Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease. , 2007, Mayo Clinic proceedings.

[16]  J. Bourbeau,et al.  Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease , 2007, Annals of Internal Medicine.

[17]  L. Ring,et al.  Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions , 2007, Pharmacoepidemiology and drug safety.

[18]  J. van der Palen,et al.  Comparison of the Diskus inhaler and the Handihaler regarding preference and ease of use. , 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[19]  Jan B. Oostenbrink,et al.  Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain , 2007, The European Journal of Health Economics.

[20]  G. Alexopoulos,et al.  An intervention to improve depression care in older adults with COPD , 2007, International journal of geriatric psychiatry.

[21]  T. Lasserson,et al.  Inhaled corticosteroids for stable chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[22]  T. Lasserson,et al.  Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[23]  T. Lasserson,et al.  Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[24]  G. Crompton The adult patient’s difficulties with inhalers , 2007, Lung.

[25]  T. Lim,et al.  Evaluating the pharmacoeconomic effect of adding tiotropium bromide to the management of chronic obstructive pulmonary disease patients in Singapore. , 2006, Respiratory medicine.

[26]  H. Luk,et al.  Teaching chronic obstructive airway disease patients using a metered-dose inhaler. , 2006, Chinese medical journal.

[27]  Saunak Sen,et al.  Polypharmacy and Prescribing Quality in Older People , 2006, Journal of the American Geriatrics Society.

[28]  T. Lasserson,et al.  Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.

[29]  J. Oppenheimer Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines , 2006 .

[30]  Kathleen C Insel,et al.  The Negative Association of Independent Personality and Medication Adherence , 2006, Journal of aging and health.

[31]  Parisa Aslani,et al.  Enhancing patient education about medicines: factors influencing reading and seeking of written medicine information , 2006, Health expectations : an international journal of public participation in health care and health policy.

[32]  P Zabel,et al.  [Chronic obstructive pulmonary disease (COPD)]. , 2006, Der Internist.

[33]  J. George,et al.  Factors associated with medication nonadherence in patients with COPD: Chest 2005;128:3198–204 , 2006 .

[34]  A. Melander,et al.  Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. , 2005, European journal of public health.

[35]  J. George,et al.  Factors associated with medication nonadherence in patients with COPD. , 2005, Chest.

[36]  R. Kaplan,et al.  Quality of life as an outcome measure in pulmonary diseases. , 2005, Journal of cardiopulmonary rehabilitation.

[37]  R. Pauwels,et al.  Relationship between respiratory symptoms and medical treatment in exacerbations of COPD , 2005, European Respiratory Journal.

[38]  Emily R. Hajjar,et al.  Unnecessary Drug Use in Frail Older People at Hospital Discharge , 2005, Journal of the American Geriatrics Society.

[39]  J. L. Rau The inhalation of drugs: advantages and problems. , 2005, Respiratory care.

[40]  D. Nash,et al.  Pharmacy utilization and the Medicare Modernization Act. , 2005, The Milbank quarterly.

[41]  R. Rodríguez-Roisín The Airway Pathophysiology of COPD: Implications for Treatment , 2005, COPD.

[42]  H. Smyth Propellant-driven metered-dose inhalers for pulmonary drug delivery , 2005, Expert opinion on drug delivery.

[43]  J. L. Rau,et al.  Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. , 2005, Chest.

[44]  M. Hyland,et al.  A qualitative study of compliance with medication and lifestyle modification in Chronic Obstructive Pulmonary Disease (COPD). , 2004, Primary care respiratory journal : journal of the General Practice Airways Group.

[45]  A. C. Moore,et al.  Meeting the needs of patients with COPD: patients' preference for the Diskus inhaler compared with the Handihaler , 2004, International journal of clinical practice.

[46]  B. Stuart Navigating the new Medicare drug benefit. , 2004, The American journal of geriatric pharmacotherapy.

[47]  R. Kaplan,et al.  Behavioral Interventions for Patients with COPD , 2004 .

[48]  P. Calverley,et al.  Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.

[49]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[50]  B. Make Chronic obstructive pulmonary disease: developing comprehensive management. , 2003, Respiratory care.

[51]  N. Anthonisen,et al.  Contemporary management of chronic obstructive pulmonary disease: scientific review. , 2003, JAMA.

[52]  N. Hanania,et al.  The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD , 2003 .

[53]  R. Pauwels,et al.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.

[54]  R. Sansores,et al.  Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[55]  N. Hanania,et al.  The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. , 2003, Chest.

[56]  P. Burkhart,et al.  Adherence to long-term therapies: evidence for action. , 2003, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[57]  J. Yates,et al.  Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[58]  L. Rubenstein,et al.  Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers. , 2002, The American journal of managed care.

[59]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[60]  C. M. Roberts,et al.  Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease. , 2002, Respiratory medicine.

[61]  R. Goldstein,et al.  The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease. , 2002, Canadian respiratory journal.

[62]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[63]  V. Plaza,et al.  Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[64]  S. Smith,et al.  The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation. , 2002, Health technology assessment.

[65]  B. Penninx,et al.  Determinants of an incorrect inhalation technique in patients with asthma or COPD. , 2001, Scandinavian journal of primary health care.

[66]  M. De Salvo,et al.  In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. , 2001, Chest.

[67]  M. Pahor,et al.  Predicting length of stay of older patients with exacerbated chronic obstructive pulmonary disease , 2001, Aging.

[68]  Morris Weinberger,et al.  Suboptimal Prescribing in Older Inpatients and Outpatients , 2001, Journal of the American Geriatrics Society.

[69]  P. Barry,et al.  Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. , 2001, Health technology assessment.

[70]  P. Cardon,et al.  A qualitative study. , 2001 .

[71]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[72]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[73]  S. Ramsey,et al.  Suboptimal medical therapy in COPD: exploring the causes and consequences. , 2000, Chest.

[74]  M. Biraghi,et al.  Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. , 2000, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[75]  P. Bakke,et al.  How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? , 1999, American journal of respiratory and critical care medicine.

[76]  K. Farmer,et al.  Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. , 1999, Clinical therapeutics.

[77]  L. Sichletidis,et al.  BRONCHODILATORY RESPONSES TO FORMOTEROL, IPRATROPIUM, AND THEIR COMBINATION IN PATIENTS WITH STABLE COPD , 1999, International journal of clinical practice.

[78]  A. Haycox,et al.  Clinical guidelines—the hidden costs , 1999, British medical journal.

[79]  N. Gross,et al.  Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary Disease , 1998, Respiration.

[80]  I. Mesters,et al.  Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.

[81]  J. J. Klein,et al.  Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.

[82]  J. J. Klein,et al.  Evaluation of the long-term effectiveness of three instruction modes for inhaling medicines. , 1997, Patient education and counseling.

[83]  B. Strom,et al.  Impact of pharmaceutical underutilization: a study of insurance drug claims data. , 1997, Journal of the American Pharmaceutical Association.

[84]  G. Cochrane,et al.  Psychological factors associated with use of home nebulized therapy for COPD. , 1996, The European respiratory journal.

[85]  J. J. Klein,et al.  Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease. , 1995, Thorax.

[86]  J. Nilsson,et al.  Large Differences between Prescribed and Dispensed Medicines Could Indicate Undertreatment , 1995 .

[87]  M. Cowles,et al.  Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. , 1995, American journal of respiratory and critical care medicine.

[88]  N. Anthonisen,et al.  Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. , 1995, Chest.

[89]  J. V. D. Palen,et al.  Matige techniek bij het gebruik van inhalatiemedicatie door patiënten met chronische bronchitis/longemfyseem , 1994 .

[90]  D. Parry,et al.  Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? , 1994, The European respiratory journal.

[91]  K. Grathwohl,et al.  Misuse of metered-dose inhalers in hospitalized patients. , 1994, Chest.

[92]  J. J. Klein,et al.  [Poor technique in the use of inhalation drugs by patients with chronic bronchitis/pulmonary emphysema]. , 1994, Nederlands tijdschrift voor geneeskunde.

[93]  N. Pearce,et al.  A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. , 1993, Current medical research and opinion.

[94]  B. Niggemann Substitution of metered-dose inhalers for hand-held nebulizers. , 1993, Chest.

[95]  C. Rand,et al.  Metered-dose inhaler adherence in a clinical trial. , 1992, The American review of respiratory disease.

[96]  B. Zimmerman,et al.  Patient compliance. Are we wasting our time and don't know it? , 1992, The American review of respiratory disease.

[97]  G. Crompton,et al.  Breath-actuated inhalers in chronic asthma: comparison of Diskhaler and Turbohaler for delivery of beta-agonists. , 1992, The European respiratory journal.

[98]  C. van Weel,et al.  Treatment with inhaled steroids in asthma and chronic bronchitis: long-term compliance and inhaler technique. , 1992, Family practice.

[99]  E. Haponik,et al.  Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital. , 1992, Chest.

[100]  S. Mcphee,et al.  Undermedication Among Geriatric Outpatients: Results of a Randomized Controlled Trial , 1992, Annual Review of Gerontology and Geriatrics.

[101]  G. Cochrane Therapeutic compliance in asthma; its magnitude and implications. , 1992, The European respiratory journal.

[102]  W. Bailey,et al.  Medication adherence patterns in chronic obstructive pulmonary disease. , 1991, Chest.

[103]  S. Bartuś,et al.  Noncompliance in organ transplant recipients. , 1990, Transplantation.

[104]  D. Hull,et al.  Noncompliance in Organ Transplant Recipients , 1989, Transplantation.

[105]  B. Juknialis,et al.  Inhaled Aerosol Bronchodilators , 1986 .

[106]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[107]  P. N. James,et al.  Patterns of drug taking in patients with chronic airflow obstruction. , 1985, Postgraduate medical journal.

[108]  G. Snider,et al.  Distinguishing among asthma, chronic bronchitis, and emphysema. , 1985, Chest.

[109]  D. Taylor,et al.  Patient compliance with oral theophylline therapy. , 1984, British journal of clinical pharmacology.

[110]  J. Winter Do patients cash prescriptions? , 1982, British medical journal.

[111]  P. Frith,et al.  Compliance with aerosol therapy in chronic obstructive lung disease. , 1981, The New Zealand medical journal.

[112]  L. Green,et al.  Health promotion and maintenance for patients with chronic obstructive pulmonary disease: a review. , 1980, Journal of chronic diseases.

[113]  A. Strauss Chronic illness and the quality of life , 1975 .

[114]  P Ley,et al.  A method for increasing patients' recall of information presented by doctors , 1973, Psychological Medicine.

[115]  Masoud Parsania,et al.  THE PATIENTS , 1982, California state journal of medicine.